Vanguard Group Inc Intellia Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,190,053 shares of NTLA stock, worth $76.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,190,053

Previous 9,627,804 5.84%

Holding current value

$76.4 Million

Previous $198 Million 39.95%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$11.41 - $21.09 $6.42 Million - $11.9 Million	562,249 Added 5.84%	10,190,053 $119 Million
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $10.4 Million - $14.4 Million	527,736 Added 5.8%	9,627,804 $198 Million
Q2 2024 Aug 13, 2024	BUY	$20.02 - $27.22 $127,247 - $173,010	6,356 Added 0.07%	9,100,068 $204 Million
Q1 2024 May 10, 2024	BUY	$23.82 - $32.8 $17.8 Million - $24.5 Million	746,263 Added 8.94%	9,093,712 $250 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $3.6 Million - $5.03 Million	155,579 Added 1.9%	8,347,449 $255 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $212,454 - $307,595	6,719 Added 0.08%	8,191,870 $259 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $1.81 Million - $2.41 Million	52,373 Added 0.64%	8,185,151 $334 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $10.7 Million - $14.5 Million	322,552 Added 4.13%	8,132,778 $303 Million
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $39.6 Million - $74.8 Million	1,192,903 Added 18.03%	7,810,226 $272 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $5.83 Million - $7.75 Million	108,041 Added 1.66%	6,617,323 $370 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $4.52 Million - $8.94 Million	117,342 Added 1.84%	6,509,282 $337 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $2.94 Million - $6 Million	-50,415 Reduced 0.78%	6,391,940 $465 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $8.97 Million - $12.3 Million	89,021 Added 1.4%	6,442,355 $762 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $43.3 Million - $57.8 Million	327,157 Added 5.43%	6,353,334 $852 Million
Q2 2021 Aug 13, 2021	BUY	$60.88 - $161.91 $367 Million - $976 Million	6,026,177 New	6,026,177 $976 Million

Others Institutions Holding NTLA

# of Institutions

332

Shares Held

95.3M

Call Options Held

1.06M

Put Options Held

863K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $570M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Intellia Therapeutics, Inc. Transaction History